Tenax Therapeutics, Inc. (TENX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -9.31M | -13.41M | -9.15M | -6.26M | -6.97M | -3.53M | -3.09M | -3.03M | -5.17M | -1.17M | -2.08M | -922.97K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -33.62% | -280.35% | -196.54% | -106.63% | -34.86% | -200.29% | -48.35% | -228.4% | -199.5% | 49.22% | 37.52% | 73.1% |
| Net Income | -15.72M | 37.06M | -15.8M | -10.85M | -10.41M | -6.27M | -3.96M | -3.58M | -3.8M | -3.23M | -1.97M | -1.11M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.71K | 969 | 1K |
| Stock-Based Compensation | 2.84M | -14.37M | 5.62M | 4.61M | 4.14M | 0 | 0 | 22K | 119K | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | -33.44M | 0 | 0 | 0 | 969.1K | 20.9K | 9K | 8K | 39.83K | 45.26K | 56.1K |
| Working Capital Changes | 3.57M | -2.67M | 1.03M | -25K | -701K | 1.77M | 852.27K | 513K | -1.49M | 2.01M | -155.4K | 126.27K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 677.6K | -18K | -648.53K | -96.81K | 204.85K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 305K | 432K | 5.05M | -1.28M | -1.32M | 1.61M | 1.09M | -221K | -1M | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.6K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.6K |
| Cash from Financing | 30.5M | 11.61M | 3.06M | 278K | 23.56M | 67.25K | 92.01M | -134K | 7.92M | -174.47K | -171.28K | -99.91K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | -97 | -278.8K | -134K | -88K | -174.47K | -171.28K | -168.16K |
| Equity Issued (Net) | 30.5M | 11.61M | 3.06M | 278K | 23.56M | 67.34K | 92.29M | 0 | 6.52M | 0 | -282.65K | 68.25K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.49M | 0 | 282.65K | 0 |
| Net Change in Cash | 21.19M | -1.8M | -6.09M | -5.99M | 16.6M | -3.46M | 88.93M | -3.17M | 2.76M | -1.35M | -2.25M | -1.02M |
| Free Cash Flow | -9.31M | -13.41M | -9.15M | -6.26M | -6.97M | -3.53M | -3.09M | -3.03M | -5.17M | -1.17M | -2.08M | -922.97K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -33.62% | -280.35% | -196.54% | -106.63% | -34.86% | -200.29% | -48.35% | -228.4% | -199.5% | 49.13% | 37.52% | 73.1% |
| FCF per Share | -0.21 | -0.34 | -0.23 | -0.16 | -0.19 | -0.23 | -0.15 | -1.55 | -4.24 | -4.73 | -6.98 | -3.34 |
| FCF Conversion (FCF/Net Income) | 0.59x | 0.86x | 0.58x | 0.58x | 0.67x | 0.56x | 0.78x | 0.85x | 1.36x | 0.36x | 1.06x | 0.83x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9K | 8K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |